Association between labor union presence and return to work after occupational injury or illness: A nationally representative longitudinal study in South Korea

Author(s):  
Bokyoung Choi ◽  
Jinwook Bahk ◽  
Hyemin Lee ◽  
Seung‐Sup Kim
BMJ Open ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. e039948
Author(s):  
Suk Won Bae ◽  
Inchul Jeong ◽  
Jin-Ha Yoon ◽  
Seung Wook Lee ◽  
Tae Hyun Kim ◽  
...  

ObjectiveThis study aims to compare workers’ income before and after an occupational injury, with regard to return to work and job retention, over a period of 5 years.DesignThis study was designed as a longitudinal study.SettingThe Panel Study of Workers’ Compensation Insurance (PSWCI) survey targeted workers involved in industrial accidents for which medical care was terminated in the year 2012.ParticipantsThe panel study was conducted on a final sample of 2000 workers who were selected proportionally by region (nine regions) after priority assignment by disability rating (six levels). A total of 1458 workers were finally included in this study.MethodsThis study used data from the first to fifth PSWCI. To identify the effect on income after occupational injury considering return to work and job retention, we used the generalised estimating equation.ResultsIn regard to workers’ return to work, the OR that income after an occupational injury would be higher than that before an occupational injury was 3.17 (2.41–4.17) for those who returned to original work and 2.32 (1.81–2.97) for those re-employed as compared with who did not return to work and 1.27 (1.07–1.15) for those who retained their job as compared with those who did not. The ORs were 2.91 (2.26–3.75) for those who were re-employed and retained jobs and 2.96 (2.15–4.08) for those who returned to original work and did not retain jobs as compared with those who did not return to work and did not retain jobs.ConclusionsIt is important for accident victims to retain their jobs to maintain their economic status.


2021 ◽  
Vol 3 (4) ◽  
pp. 239-249
Author(s):  
Michael J. Booth ◽  
Daniel Clauw ◽  
Mary R. Janevic ◽  
Lindsay C. Kobayashi ◽  
John D. Piette

BMJ Open ◽  
2017 ◽  
Vol 7 (10) ◽  
pp. e016358 ◽  
Author(s):  
Nafeesa N Dhalwani ◽  
Radia Fahami ◽  
Harini Sathanapally ◽  
Sam Seidu ◽  
Melanie J Davies ◽  
...  

ObjectivesAssess the longitudinal association between polypharmacy and falls and examine the differences in this association by different thresholds for polypharmacy definitions in a nationally representative sample of adults aged over 60 years from England.DesignLongitudinal cohort study.SettingThe English Longitudinal Study of Ageing waves 6 and 7.Participants5213 adults aged 60 or older.Main outcome measuresRates, incidence rate ratio (IRR) and 95% CI for falls in people with and without polypharmacy.ResultsA total of 5213 participants contributed 10 502 person-years of follow-up, with a median follow-up of 2.02 years (IQR 1.9–2.1 years). Of the 1611 participants with polypharmacy, 569 reported at least one fall within the past 2 years (rate: 175 per 1000 person-years, 95% CI 161 to 190), and of the 3602 participants without polypharmacy 875 reported at least one fall (rate: 121 per 1000 person-years, 95% CI 113 to 129). The rate of falls was 21% higher in people with polypharmacy compared with people without polypharmacy (adjusted IRR 1.21, 95% CI 1.11 to 1.31). Using ≥4 drugs threshold the rate of falls was 18% higher in people with polypharmacy compared with people without (adjusted IRR 1.18, 95% CI 1.08 to 1.28), whereas using ≥10 drugs threshold polypharmacy was associated with a 50% higher rate of falls (adjusted IRR 1.50, 95% CI 1.34 to 1.67).ConclusionsWe found almost one-third of the total population using five or more drugs, which was significantly associated with 21% increased rate of falls over a 2-year period. Further exploration of the effects of these complex drug combinations in the real world with a detailed standardised assessment of polypharmacy is greatly required along with pragmatic studies in primary care, which will help inform whether the threshold for a detailed medication review should be lowered.


2017 ◽  
Vol 27 (12) ◽  
pp. 763-770 ◽  
Author(s):  
Chia Wei ◽  
Susan G. Gerberich ◽  
Andrew D. Ryan ◽  
Bruce H. Alexander ◽  
Timothy R. Church ◽  
...  

2021 ◽  
pp. 1-6
Author(s):  
Philip Hyland ◽  
Frédérique Vallières ◽  
Orla McBride ◽  
Jamie Murphy ◽  
Mark Shevlin ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document